NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.
Dr. Nancy JOSEPHRIDGE
Takeda Unveils PostTAP Executive Structure
Takeda Pharmaceuticals North America (TPNA), Deerfield, Ill., has announced leader ship changes as part of the closing of TAP Pharmaceutical Products, the U.S.based joint venture between Abbott Laboratories and TPNA’s Japanese parent, Takeda Pharmaceu tical Co. Ltd. Nancy JosephRidge, M.D., formerly VP of research and development at TAP, has been appointed president of Takeda Global Research & Development Center (TGRD). Before joining TAP in 2002, Dr. Joseph Ridge worked in drug safety and clinical development at Searle, now part of Pfizer. She received an M.D. from the University of Illi nois at Chicago. Alan MacKenzie, formerly president of TAP and a president of TPNA, has been named executive VP of Takeda America Hold ings (TAH) and CEO of TPNA. TPNA pres ident Mark Booth is remaining with the com pany temporarily to support integration activities following the closure of the TAP transaction. Mr. MacKenzie joined TAP in 1985 as a sales representative. He received a BSN from Wagner College, a B.A. in economics from City University of New York, and an MBA from the University of Chicago. Robert LAVERTY Eisai Appoints Communications VP Eisai Corporation of North America, Woodcliff Lake, N.J., has named Robert Laverty to the newly created position of VP of U.S. corporate communications. Mr. Laverty was most recently VP, global communica tions, malaria initiatives, for Novartis. He received a B.S. in pharmacy from St. John’s University. Paul ROMNESS Dr. Philip VICKERS Boehringer Ingelheim Adds to Executive Team Boehringer Ingelheim, Ridgefield, Conn., has appointed Paul Romness VP of government affairs and public policy. Mr. Romness’ responsibilities include executing plans at the federal and state levels through the development of regulation, legislation, and policy, as well as leading the management of the Boehringer Ingelheim Cares Patient Assistance Program, the Boehringer Ingelheim Product Donation Program, and the Boehringer Ingelheim Cor poration Political Action Committee (BIC PAC). Most recently, Mr. Romness was principal at PR Strategies. He received a B.S. in finance from American University and a master’s in health policy from George Washington Uni versity Medical Center. Philip Vickers, Ph.D., has joined Boehringer Ingelheim as senior VP of research. Dr. Vickers is responsible for overseeing research activities at Boehringer Ingelheim’s U.S. headquarters and is also a member of the Ger man company’s global research leadership team. TALENT POOL EXECUTIVE APPOINTMENTS AND PROMOTIONS IN THE HEALTHCARE INDUSTRY Most recently, Dr. Vickers served as VP of global research and development at Pfizer and site head of the Pfizer Research Technology Center in Cambridge, Mass. He received a B.S. in applied biochemistry from the Univer sity of Salford in Manchester, United King dom, and a Ph.D. in biochemistry from the University of Toronto. Biotech POOL Dr. Gordon PARRY Monogram Biosciences Promotes Research VP Monogram Bio sciences, South San Fran cisco, Calif., has promot ed Gordon Parry, Ph.D., to VP, research and devel opment, oncology, from senior director of research and development, oncolo gy. Dr. Parry is responsi ble for Monogram’s oncology R&D programs, including further development of Monogram’s proprietary VeraTag technology platform and the first product based on that platform, the HERMark Breast Cancer Assay. Dr. Parry received a Ph.D. in biochemistry from the University of London. Biopharmaceutical POOL Randall ST. LAURENT ARCA Shifts Focus to Commercialization ARCA Discovery, Denver, has changed its name to ARCA biopharma to reflect its focus on the commercialization of its cardiovascular drug candidates. As part of this transformation, the compa ny has appointed Randall St. Laurent execu tive VP of commercial operations, with initial responsibility for supporting the approval application for ARCA’s lead product, the next generation betablocker and vasodilator bucindolol. Mr. St. Laurent was most recently VP of commercial development at Scios. He received a bachelor’s degree with a major in marketing from The Ohio State University. 102 J un e 2 008 PharmaVOICE PV0608 Layout FINAL2 5/20/08 12:48 AM Page 102 TALENT pool Specialty POOL Dr. Ernie BICZAK Richard DESIMONE Stephen HULSE Dave IWANICKI Dr.Tong ZHANG EKR Therapeutics Adds to Management Team EKR Therapeutics, Cedar Knolls, N.J., a specialty pharmaceutical company focused on acutecare products, has made a number of additions to its executive team. Ernie Biczak, M.D., has joined EKR as senior VP of marketing, from Esprit Pharma, where he served as executive VP, medical affairs. He received an M.D. from Rutgers Medical School. EKR cofounder Richard DeSimone has been named chief operating officer. Mr. DeSi mone previously served as chief financial offi cer and a company director. Stephen Hulse, R.Ph., has been named VP of sales. Mr. Hulse was most recently director of sales, central area, for PDL BioPharma. He is a graduate of Albany College of Pharmacy, Union University. Dave Iwanicki has joined EKR as senior VP of commercial operations from PDL Bio Pharma, where he was VP, sales, and sales operations and corporate officer. He received a B.S. in business administration from Western New England College. Tong Zhang, Ph.D., has been promoted to VP of business development. Since joining EKR in early 2007, Dr. Zhang’s responsibili ties have centered on pursuing opportunities to leverage EKR’s commercial organization. He received a B.S. in biology from Wuhan University in China and a Ph.D. in biology from Columbia University. Mike BOGDA Christine MUNDKUR Timothy SAWYER G. Frederick WILKINSON Barr Restructures Leadership Barr Pharmaceuticals, Montvale, N.J., has announced a number of promotions as part of a restructuring of its senior management team to better align the company’s global generic and proprietary businesses, optimize opera tions, and increase efficiencies across the orga nization worldwide. Mike Bogda has been promoted to president and chief operating offi cer of Barr Laboratories, the company’s generic pharmaceuticals busi ness. Mr. Bogda was previ ously Barr’s executive VP, global product supply. He continues to over see all aspects of global product supply, with additional responsibility for quality and phar ma chemicals. Mr. Bogda received an M.S. in chemical engineering from Rutgers University and an MBA from the Wharton School of the Uni versity of Pennsylvania. Christine Mundkur has been named CEO of Barr Laboratories, with responsibility for leading the global generics busi ness. Most recently, Ms. Mundkur served as execu tive VP, global quality, safety, and regulatory affairs at the company. She holds a B.S. in chemistry from Saint Louis University and a J.D. from Saint Louis University School of Law. Timothy Sawyer has been promoted to execu tive VP, global generic sales and marketing, with responsibility for Barr’s generic commercial oper ations around the world. Mr. Sawyer was previous ly Barr’s senior VP of European commercial development. He has a bachelor’s degree from the Uni versity of Richmond. G. Frederick Wilkin son has been promoted to the newly created posi tion of CEO of Duramed Pharmaceuticals, the company’s proprietary products business. Mr. Wilkinson was previously president and chief operating officer of Duramed. In addition to managing product selection, clinical development, and sales and marketing at Duramed, Mr. Wilkinson continues to direct Barr’s growing global biologics devel opment program. He earned a B.S. in pharmacy from Ohio Northern University and an MBA from Capi tal University. Dr. Gavin CORCORAN Stiefel Promotes Head of R&D Stiefel Laboratories, a dermatology specialty company based in Coral Gables, Fla., has promot ed Gavin Corcoran, M.D., FACP, to chief scientific officer, a position created to reinforce the critical role played by the compa ny’s research and development organization and to further strengthen collaboration among Stiefel’s five global R&D facilities. Dr. Corco ran was most recently senior VP, global research and development. As chief scientific officer, Dr. Corcoran oversees global scientific and operational activities related to product development and support, medical and scientific affairs, clinical and preclinical research, pharmacovigilance, portfolio planning, and regulatory affairs. He received a medical degree from University of the Witwatersrand in Johannesburg, South Africa. George ESGRO Cornerstone BioPharma Appoints Sales VP Cornerstone BioPharma, Cary, N.C., a spe cialty pharmaceutical company that focuses on the development and commercialization of prescription medications in the respiratory market, has named George Esgro VP of sales and marketing. A 20year industry veteran, Mr. Esgro most recently was east regional sales director at Roche. He received a business degree from James Madison University. Dr. Anthony FOX Conatus Selects PartTime Medical Chief Conatus Pharmaceuticals has appointed Anthony Fox, M.D., Ph.D., as a parttime chief medical officer. Conatus, San Diego, is a specialty pharmaceutical company developing therapeutics to treat liver disease. Dr. Fox’s primary responsibility at Conatus is to oversee the recently initiated Phase II clinical trial of CTS1027 in patients infected with the hepatitis C virus, as well as assisting with longerterm clinical development plans. In addition to this role, Dr. Fox continues to serve as president of EBD Consulting. He has a bachelor’s degree in pharmacolo gy, earned his medical degree at the London Hospital (now Royal), and received a doctorate on quantitative drugreceptor interactions from the University of London. 103 PharmaVOICE J un e 200 8 PV0608 Layout FINAL2 5/20/08 12:48 AM Page 103 TALENT pool Regulatory POOL Dr. Frank TORTI FDA Creates Chief Scientist Post The U.S. Food and Drug Administration has appointed Frank Torti, M.D., MPH, principal deputy commissioner and the agency’s first chief scientist. In these roles, Dr. Torti is supporting the launch of the FDA Fellowship Program, which has the potential to attract up to 2,000 professionals of varying disciplines for a two year training program. The newly created position stems from the Food and Drug Administration Amendments Act of 2007. The new office is working to ensure the quality and regulatory focus of the FDA’s intramural research programs, with special emphasis on the importance of clinical research trials that are a part of the foundation of the FDA’s regulatory structure. A prominent clinician, scientist, and researcher in molecular oncology, Dr. Torti is currently serving as Charles L. Spurr professor of medicine, chair of the Department of Can cer Biology, and director of the Comprehen sive Cancer Center at Wake Forest University School of Medicine. He received his bachelor’s and master’s degrees from The Johns Hopkins University, his M.D. from Harvard Medical School, and his MPH from Harvard School of Public Health. He currently serves on the National Insti tutes of Health’s National Advisory Council for Complementary and Alternative Medicine. Dr. Torti also founded and serves as Presi dent of the Cancer Biology Training Consor tium. Agency POOL Erika ANTONUCCI Eric CALE Molly LARSEN Michelle SAMENFELD Meredith Keroff WEBER AbelsonTaylor Expands Account Services Independent healthcare advertising agency AbelsonTaylor, Chicago, has announced a number of appointments in its account ser vices area. Erika Antonucci has been promoted to senior account supervisor from account supervisor. Ms. Antonucci contin ues to serve as the dayto day strategic and tactical lead for an account in the sleep category at the agency. She received a B.S. in marketing and finance from Marquette University. Eric Cale has joined AbelsonTaylor as account executive, with responsi bility for a product for the treatment of GERD. Mr. Cale was most recently an associate account executive at Williams Labadie. He earned a B.S. in marketing from the Kelley School of Business, Indiana University. Molly Larsen has been promoted to senior account executive from account executive. Ms. Larsen has respon sibility for managing accounts in the osteo porosis area. She holds a B.A. in psychology from Northwestern University. Dr. Mikael DOHLSTEN Dr. Robert R. RUFFOLO JR. Wyeth Names President of R&D Wyeth, Madison, N.J., has announced that Robert R. Ruffolo, Jr., Ph.D., 58, will retire as president of Wyeth Research and senior VP, Wyeth, later this year. He will be succeeded by Mikael Dohlsten, M.D., Ph.D. Dr. Ruffolo joined Wyeth in November 2000 and has been responsible for all phar maceutical research and development (R&D) for the company, including discov ery, drug safety and metabolism, chemical and pharmaceutical development, clinical R&D, and research operations. Throughout his 31year career in the pharmaceutical industry, Dr. Ruffolo’s work has been recognized with a number of prestigious awards. In March, he was recognized by the Pharmaceutical Research and Manufactur ers of America (PhRMA) with the 2008 Discoverer’s Award for his efforts in the dis covery and development of Coreg while at GlaxoSmithKline. The Wyeth Research and Development Executive Team (RADEX), formed and chaired by Dr. Ruffolo, won the 2006 Scrip Award for Management Team of the Year. In 2005, he won the George B. Koelle Award for Scientific Excel lence. In 2004, he was named Chief Scientific Officer of the Year by IBC Conferences. Dr. Dohlsten, 49, previous ly was executive VP within pharmaceutical research and development/medicine at Boehringer Ingelheim. He was responsible for leading the company’s worldwide pharma ceutical research in the United States, Canada, Germany, Italy, Austria, and Japan. In addition, he was a member of the corporate management team responsible for review ing all worldwide development projects and licensing opportunities. Before joining Boehringer Ingelheim, Dr. Dohlsten spent more than 15 years in various leadership roles in pharmaceutical research, including positions with AstraZeneca and Pharmacia & Upjohn. Dr. Dohlsten earned his Ph.D. in tumor immunology and M.D. from the Universi ty of Lund in Sweden. He also studied virology and cell biolo gy at the Weizmann Institute in Israel and has been appointed as adjunct professor in immunology at the medical faculty in Lund. Dr. Robert R. Ruffolo Jr. 104 J un e 2 008 PharmaVOICE WYETH READIES FOR R&D SUCCESSION PV0608 Layout FINAL2 5/20/08 12:48 AM Page 104 TALENT pool Michelle Samenfeld has joined the agency as account executive, responsible for managing an account for the treat ment of acid reflux. Ms. Samenfeld was previously a senior account executive at Cor bett Worldwide Health Communications. She received a B.A. in journalism from the University of WisconsinMadison’s School of Journalism and Mass Communication. Meredith Keroff Weber has been promoted to senior account supervi sor from account supervi sor. Ms. Weber has experi ence in a wide range of therapeutic categories, including infectious dis ease, allergic rhinitis, chronic idiopathic urticaria, allergic conjunctivitis, and overac tive bladder. She received a bachelor’s of general studies in communications from the University of Kansas. Stephen BINGHAM JFK Communications Appoints VP Healthcare publicrelations firm JFK Communications, Princeton, N.J., has named Stephen Bingham VP, with responsibility for overseeing the agency’s growing list of phar maceutical, specialty pharma, and medical technology clients. Mr. Bingham has 20 years of healthcare communications experience. Most recently, he was as a senior member of the Caunos Group. He previously ran his own firm, Bingham Associates. Elizabeth CASTILLO Derev DIGGS Courtney HUTCHINS Kevin KASZUBA Shane MAYER Buddy SCALERA Qi Promotes and Expands Creative and Account Staff Qi, a fullservice digital agency and part of CommonHealth, has announced several pro motions and additions to its creative and account teams. At the Parsippany, N.J.based agency Eliza beth Castillo has been promoted to group art supervisor of interactive media from her previous role as senior graphic designer. Ms. Castillo’s core responsibilities include the implementation of best practices in design, infrastructure archi tecture, application of animation, video, online branding, and social media marketing. Derev Diggs has joined Qi as a senior interactive media devel oper. Previously, Mr. Diggs was a senior multimedia developer at Temel, now known as Zeta Interac tive. Courtney Hutchins has joined Qi as an emar keting associate from HLS, CommonHealth’s founding medicaleduca tion unit. In this role at Qi, Ms. Hutchins manages inter active content projects, monitors industry trends, and develops new market ing and advertising pro grams. Kevin Kaszuba has been named a motion designer/video editor. Before joining Qi, Mr. Kaszuba was a senior interactive designer at JDK Design. Shane Mayer has been appointed an account supervisor, with responsi bility for managing the tactical planning process es for interactive strate gies, focusing on the development and imple mentation of marketing plans. Mr. Mayer was most recently a senior mar keting manager at WebMD. Buddy Scalera has been promoted to VP, interactive content and market research, from senior director, interactive content and market research. In this role, Mr. Scalera oversees the digi tal team and researches, develops, and delivers new interactive online strategies, including social and viral marketing, Web content, searchengine marketing campaigns, and mobile applications. Jason CHIN Alla LITOVCHENKO Bruce MACINDOE Matt THORSEN Seidler Bernstein Adds to Creative Group Seidler Bernstein, Cambridge, Mass., a fullservice marketing communications agen cy specializing in healthcare and life technolo gies, has announced a number of additions to its creative team. Jason Chin has joined Seidler Bernstein as inter active art director from Digitas, where he served as a senior design consul tant. Mr. Chin holds a BFA in industrial design from the Massachusetts College of Art. Alla Litovchenko has been promoted to associ ate creative director, art. Ms. Litovchenko has been with Seidler Bernstein since 2003 and is respon sible for many of the agency’s awardwinning designs, including work for Bayer Healthcare Diagnostics, Boston Sci entific, GE, PerkinElmer, and Quest Diagnos tics. She is a graduate of the Academy of Arts School in Chernigov, Russia. Bruce Macindoe has joined Seidler Bernstein as senior art director. Mr. Macindoe held the same position at the Pappas Group. He holds a BFA in graphic design from the Norwich School of Art in the United Kingdom. Matt Thorsen has joined the agency as director of creative ser vices. A 20year agency veteran, Mr. Thorsen has held a number of creative and production positions at agencies such as Arnold Worldwide, Philip John son Associates, and Orsatti and Partners. 105 PharmaVOICE J un e 200 8 PV0608 Layout FINAL2 5/20/08 12:48 AM Page 105 TALENT pool Katherine CUNDIFF David GOLDFARB Chris KEEFE Karen MELANSON Peter SIEGEL Pacific Communications Makes Staff Changes Pacific Communications, Costa Mesa, Calif., has announced a number of promotions and additions to its account and creative teams. Katherine Cundiff has joined Pacific as an account group supervisor for Allergan Medi cal Global. Ms. Cundiff was previously responsible for strategic planning, global launches, and account management at Mind share Creative and was in charge of oversee ing aesthetics accounts for CommuniQu Marketing. David Goldfarb has been promoted to asso ciate creative director/copy, responsible for the Allergan Therapeutics and Medical Dermatol ogy accounts. Mr. Goldfarb has been with Pacific for three years. Chris Keefe has been promoted to creative director/art. He has been with Pacific since 2002. Karen Melanson has been promoted to VP director of client services, with responsibility for overseeing the Allergan Medical Dermatology, Medtronic, Advanced Sterilization Products/ J&J, Inspire, and Prometheus accounts. Ms. Melanson has been with Pacific for 15 years and has been involved in nearly every client area for the agency. Healthcare advertising veteran Peter Siegel has joined Pacific as executive creative director from the same position at The Hal Lewis Group. Su JANG Topin Adds Account Executive Topin & Associates, a fullservice healthcare advertising agency based in Chicago, has hired Su Jang as account executive working on the Baxter Global Medication Deliv ery account. Ms. Jang was most recently account manager at Siren Interactive. Spring MOORE Daniel SCHRIER Avenue A | Razorfish Expands Philadelphia Office Interactive services agency Avenue A | Razorfish has added two members to its Philadelphiabased staff. Spring Moore has joined as user experience lead, working with infor mation architects, design ers, and copywriters to develop interactive mod els. Ms. Moore was previ ously creative director at Solutions for Progress. She received a B.A. in fine arts from the Uni versity of Pennsylvania. Daniel Schrier was appointed senior project manager, leading Web development and interac tive media projects. Mr. Schrier was most recently editorial systems project manager for Managing Editor (MEI). He holds a B.A in English creative writing from Califor nia State University, Hayward. Sarah PHILLIPS Photosound Announces Promotion Photosound has pro moted Sarah Phillips to senior account manager. Photosound, Plainsboro, N.J., part of the Health Star Communications network of companies, is a medical communica tions and design agency with offices in the United States, the United Kingdom, and France. Marge SUTPHEN Jonathan WOOD Centron Adds Creative, Account Staff Centron, New York, has announced two additions to its creative and account teams. Marge Sutphen has joined Centron as VP, account group supervisor. Ms. Sutphen previ ously worked at Grey Healthcare. Jonathan Wood has joined the agency as creative group supervisor, from copy group supervisor at Euro RSCG Life MetaMax. Paul VENTURA EPIC Brand Adds Account Exec EPIC Brand Commu nications, Aliso Viejo, Calif., has appointed Paul Ventura account execu tive. With extensive career experience in a wide range of medical products and therapeutics for major pharmaceutical companies, Mr. Ventura was previously a senior sales specialist for Eli Lilly and a field sales representative for Merck and Ross Labo ratories, a division of Abbott Laboratories. CRO POOL Sharon DINKINS CRI Worldwide Expands Regulatory Group CRI Worldwide, Clementon, N.J., has appointed Sharon Dinkins to the newly creat ed position of director of quality assurance and regulatory affairs. Ms. Dinkins has more than 30 years of experience, most recently as direc tor, quality assurance, North America at MDS Pharma Services. She received a B.S. in crimi nal justice from Temple University. Media POOL Dr. Charles NEMEROFF New Editor at Quadrant HealthCom Journal Medical journal pub lisher Quadrant Health Com, Parsippany, N.J., has named Charles Nemeroff, M.D., Ph.D., editorinchief of Neuro Psychiatry Reviews, a monthly clinical news tabloid focused on the biological basis of psychiatry. Dr. Nemeroff received a master’s degree in biology from Northeastern University and an M.D. and Ph.D. in neurobiology from the University of North Carolina at Chapel Hill. 106 J un e 2 008 PharmaVOICE PV0608 Layout FINAL2 5/20/08 12:48 AM Page 106 TALENT pool MedicalEducation POOL Laura AIBARA Dr. Robin SMITH Staff Changes at Curry Rockefeller The Curry Rockefeller Group (CRG), New York, has added two staff members to its med icaleducation programming and editorial teams. Laura Aibara joins CRG as program direc tor. She most recently was program manager at Haymarket Medical. She received a B.A. in communications and advertising from Iona College. CRG has appointed Robin Smith, Ph.D., sci entific director. Dr. Smith is responsible for assisting in the development of strategic publication planning and implemen tation. Dr. Smith was previ ously senior executive edi tor, sciences, at Columbia University Press. He received a B.S. with hon ors in cell and molecular biology from King’s Col lege at the University of London and a Ph.D. in biochemistry from the University of Cambridge’s Medical Research Council Laboratory of Molecular Biology. Service POOL Randi BOGARD Matt GLAVAS Richard “Tex” KUND Sidhartha RAO Algis “Al” SALCIUNAS Clement SMITH MTI Adds to Staff MTI, a provider of pharmaceutical mar keting products in Langhorne, Pa., has made several additions to its staff. Randi Bogard has been appointed VP, business develop ment. In this position, Ms. Bogard is responsible for fostering existing client relationships, pro moting MTI’s pharmaceutical marketing products, and developing new business oppor tunities that support the company’s growth strategy. Before joining MTI, Ms. Bogard worked with Lathian Systems as regional sales VP. She is a graduate of Florida State University where she earned a bachelor of science in communi cations. MTI has hired Matt Glavas as director, business analytics. He is responsible for leading MTI’s business analytics team in the use of advanced statistical methodologies to generate, interpret, and present market analysis used in support of MTI’s marketing programs. Mr. Glavas has more than 18 years of pro fessional experience, seven of which were at BristolMyers Squibb. He earned his master’s in business administration from the Universi ty of North Carolina and his bachelor’s degree from the University of California. MTI has appointed Richard “Tex” Kund as VP, business development. Mr. Kund is responsible for fostering existing client rela tionships, promoting MTI’s pharmaceutical marketing products and developing new busi ness opportunities that support the company’s growth strategy. Before joining MTI, Mr. Kund held the position of director of business development for PDI, where he was responsible for identi fying potential new business within the bio pharmaceutical industry. Mr. Kund attended St. Vincent College in Latrobe, Pa., and earned a bachelor’s degree in business administration from Temple University. MTI has hired Sidhartha Rao as director, systems. In this position, Mr. Rao is responsi ble for developing and managing strategic plans for MTI’s technology infrastructure. Before joining MTI, Mr. Rao worked with Ranbaxy as chief technology architect and security officer. He received a bachelor of sci ence degree from Delhi University, Delhi, India. MTI has hired Algis “Al” Salciunas as director, product management. In this posi tion, Mr. Salciunas is responsible for maintain ing and managing product concepts, product business models and all commercial aspects of MTI’s cornerstone marketing product, Exten der. Before joining MTI, Mr. Salciunas spent nearly 16 years at IMS Health, most recently holding the position of business/competitive intelligence principal. He earned a master’s in business adminis More than 5,500 Solutions Providers The most comprehensive online directory of products and services for the lifesciences industry — featuring a wide range of products, services, and solutions for your clinical, commercial, business, and technology needs. Browse by Category . Search by Company PV0608 Layout FINAL2 5/20/08 12:48 AM Page 107 TALENT pool tration, specializing in marketing and bache lor of arts in English and journalism from Rutgers University. Additionally, Clement Smith has been appointed VP, business development. Mr. Smith is responsible for fostering existing client relationships, promoting MTI’s phar maceutical marketing products, and develop ing new business opportunities that support the company’s growth strategy. Before joining MTI, Mr. Smith worked with Princeton Softech as an account executive and was recognized for numerous accomplish ments. He earned a bachelor of arts in communi cations from The College of New Jersey. John CARRO James CASTELLO TGaS Hires Industry Veterans Amid Expansion TGaS Advisors, an East Norriton, Pa.based benchmarking company focused on pharmaceuti cal commercial opera tions, has named John Carro VP, management advisor. Mr. Carro is part of the company’s sales/sales operations practice and is responsible for existing services as well as developing innovative new solutions for clients. He was most recently VP, commercial operations, at King Pharmaceuticals. TGaS also has appointed James Castello director, management advisor, in the compa ny’s sales operations practice. Mr. Castello was previously managing director at Synygy. He received a bachelor’s degree in finance and an MBA from Pennsyl vania State University. Diana CRAWLEY Publicis Selling Solutions Names Director of New Division Publicis Selling Solu tions, a Lawrenceville, N.J.based provider of sales teams and support services to the biophar maceutical industry, has appointed Diana Crawley executive director of Pub licis Clinical Health Part ners, a new division that provides integrated, behaviorally based education programs designed to optimize patient compliance and treatment outcomes. Publicis Selling Solutions is part of the Publicis Selling Solutions Group, a Publicis Healthcare Communications Group compa ny. Ms. Crawley has 18 years of leadership and healthcare experience and six years of industry experience leading clinical health educator teams. Before joining Publicis Selling Solu tions Group, she was a project leader at a company that also provides health educator teams. She earned a B.S. in nursing from the Uni versity of Florida and an MBA from Indiana Wesleyan University. Darren HEAD Cytovance Announces New CEO Cytovance Biologics, an Oklahoma Citybased biopharmaceutical con tract manufacturing orga nization specializing in the production of thera peutic proteins and anti bodies from mammalian cell culture, has named Darren Head CEO. Mr. Head previously served as VP of world wide operations for Immucor, where he served as VP of worldwide operations, overseeing the manufacturing of biological products in the United States, Europe, and Canada. Dr. Aaron KANTOR ITI Expands Management Team The Immune Tolerance Institute (ITI) has selected Aaron Kantor, Ph.D., as its chief sci entific officer. ITI is a San Franciscobased nonprofit founded in partnership with the University of California, San Francisco (UCSF) to translate fundamental scientific discoveries into new therapies for a broad range of diseases related to the human immune system. Most recently, Dr. Kantor served as execu tive director of cell and molecular biology for biomarker discovery sciences at Pharmaceuti cal Product Development (PPD). He received a bachelor’s degree in bio physics from the University of Pennsylvania and a Ph.D. in biophysics from the University of California at Berkeley. Eva LAPARRA Jonathan SPIESS Ziment Expands Marketing, Technology Leadership Healthcare marketing research and con sulting organization Ziment Group, New York, has announced the appointment of two executives to lead its groupwide marketing and technology activities. This expansion reflects the rapid growth of Ziment Group’s four companies: Ziment Cus tom, the strategic primary marketing research division; imap Research, which provides syn dicated market tracking research; Consumer Health Sciences (CHS), which conducts the National Health and Wellness Survey, a lead ing diseasespecific consumer survey; and All Global, the market leader in global healthcare data collection. Eva Laparra has been named VP, marketing of Ziment Group, responsible for marketing and communications programs for all group companies. Ms. Laparra is a founder and former direc tor of All Global, which merged with Ziment’s WebSurveyResearch business in March. She holds a B.S. in business management and an M.S. in international business. Jonathan Speiss has joined Ziment Group as VP, technology and innovation, with responsibility for providing stateoftheart technology solutions that advance operations, marketing, and product development across all group companies. Mr. Speiss has more than 20 years of busi ness technology experience, during which he has held management positions in technology and R&D with major pharmaceutical compa nies such as BristolMyers Squibb and John son & Johnson. He also was founder, principal, and chief technology officer of Digital Resolutions, a digital marketing company. Mr. Speiss received a B.S. from the Rochester Institute of Technology and an MBA from the University of Phoenix. Tammy PENKALSKI GCG Event Partners Names Business Development Manager Tammy Penkalski has joined GCG Event Part ners as manager of busi ness development. GCG Event Partners, Stoneham, Mass., is a sup plier to the meeting plan ning industry with a focus on both CME and non CME medical meetings, particularly pharma ceutical dinner meetings. Ms. Penkalski was most recently manager of operations for a private CME company. She attended Eastern Kentucky University. # Send your personnel announcements to email@example.com. 108 J un e 2 008 PharmaVOICE PV0608 Layout FINAL2 5/20/08 12:49 AM Page 108